Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Medicinal Chemistry
|
March 11, 2026
Accurate Prediction of Core-Hopping Transformations Using Molecular Dynamics-Derived Conformational Ensembles: Application to the Discovery of Novel P2X3 Antagonists
Daniele Pala, Claudio Fiorelli, Paolo Bruno, et al.
Journal of Medicinal Chemistry
|
April 29, 2005
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter
Daniele Simoni, Marcello Rossi, Valerio Bertolasi, et al.
Angewandte Chemie (International Ed. in English)
|
December 16, 2014
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Federica Prati, Angela De Simone, Paola Bisignano, et al.
ACS Chemical Neuroscience
|
July 15, 2015
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease
Federica Prati, Angela De Simone, Andrea Armirotti, et al.
Journal of Medicinal Chemistry
|
March 17, 2020
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors
Simona Di Martino, Piero Tardia, Vincenzo Cilibrasi, et al.
Angewandte Chemie (International Ed. in English)
|
July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
Marco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.
Journal of Medicinal Chemistry
|
September 1, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration
Paolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, et al.
ACS Medicinal Chemistry Letters
|
November 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors
Daniele Pala, Paolo Ronchi, Donatella Rescigno, et al.
Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of a Novel Lung-Restricted ALK5 Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
Paolo Ronchi, Daniela Pizzirani, Daniele Pala, et al.
Journal of Medicinal Chemistry
|
December 5, 2024
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
Paolo Bruno, Daniele Pala, Alessandra Micoli, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Medicinal Chemistry
|
March 11, 2026
Accurate Prediction of Core-Hopping Transformations Using Molecular Dynamics-Derived Conformational Ensembles: Application to the Discovery of Novel P2X3 Antagonists
Daniele Pala, Claudio Fiorelli, Paolo Bruno, et al.
Journal of Medicinal Chemistry
|
April 29, 2005
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter
Daniele Simoni, Marcello Rossi, Valerio Bertolasi, et al.
Angewandte Chemie (International Ed. in English)
|
December 16, 2014
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Federica Prati, Angela De Simone, Paola Bisignano, et al.
ACS Chemical Neuroscience
|
July 15, 2015
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease
Federica Prati, Angela De Simone, Andrea Armirotti, et al.
Journal of Medicinal Chemistry
|
March 17, 2020
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors
Simona Di Martino, Piero Tardia, Vincenzo Cilibrasi, et al.
Angewandte Chemie (International Ed. in English)
|
July 13, 2016
Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis
Marco Migliore, Silvia Pontis, Angel Luis Fuentes de Arriba, et al.
Journal of Medicinal Chemistry
|
September 1, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration
Paolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, et al.
ACS Medicinal Chemistry Letters
|
November 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors
Daniele Pala, Paolo Ronchi, Donatella Rescigno, et al.
Journal of Medicinal Chemistry
|
May 19, 2026
Discovery of a Novel Lung-Restricted ALK5 Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
Paolo Ronchi, Daniela Pizzirani, Daniele Pala, et al.
Journal of Medicinal Chemistry
|
December 5, 2024
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease
Paolo Bruno, Daniele Pala, Alessandra Micoli, et al.
Page
of 3